408 related articles for article (PubMed ID: 26885856)
1. Glycogen Synthase Kinase 3 Inactivation Drives T-bet-Mediated Downregulation of Co-receptor PD-1 to Enhance CD8(+) Cytolytic T Cell Responses.
Taylor A; Harker JA; Chanthong K; Stevenson PG; Zuniga EI; Rudd CE
Immunity; 2016 Feb; 44(2):274-86. PubMed ID: 26885856
[TBL] [Abstract][Full Text] [Related]
2. The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection.
Staron MM; Gray SM; Marshall HD; Parish IA; Chen JH; Perry CJ; Cui G; Li MO; Kaech SM
Immunity; 2014 Nov; 41(5):802-14. PubMed ID: 25464856
[TBL] [Abstract][Full Text] [Related]
3. Anti-GITR agonist therapy intrinsically enhances CD8 T cell responses to chronic lymphocytic choriomeningitis virus (LCMV), thereby circumventing LCMV-induced downregulation of costimulatory GITR ligand on APC.
Clouthier DL; Zhou AC; Watts TH
J Immunol; 2014 Nov; 193(10):5033-43. PubMed ID: 25281716
[TBL] [Abstract][Full Text] [Related]
4. PD-1 Expression during Acute Infection Is Repressed through an LSD1-Blimp-1 Axis.
Bally APR; Neeld DK; Lu P; Majumder P; Tang Y; Barwick BG; Wang Q; Boss JM
J Immunol; 2020 Jan; 204(2):449-458. PubMed ID: 31811020
[TBL] [Abstract][Full Text] [Related]
5. IL-21 promotes CD8+ CTL activity via the transcription factor T-bet.
Sutherland AP; Joller N; Michaud M; Liu SM; Kuchroo VK; Grusby MJ
J Immunol; 2013 Apr; 190(8):3977-84. PubMed ID: 23479229
[TBL] [Abstract][Full Text] [Related]
6. The transcription factors ZEB2 and T-bet cooperate to program cytotoxic T cell terminal differentiation in response to LCMV viral infection.
Dominguez CX; Amezquita RA; Guan T; Marshall HD; Joshi NS; Kleinstein SH; Kaech SM
J Exp Med; 2015 Nov; 212(12):2041-56. PubMed ID: 26503446
[TBL] [Abstract][Full Text] [Related]
7. Small-Molecule Inhibition of PD-1 Transcription Is an Effective Alternative to Antibody Blockade in Cancer Therapy.
Taylor A; Rothstein D; Rudd CE
Cancer Res; 2018 Feb; 78(3):706-717. PubMed ID: 29055015
[TBL] [Abstract][Full Text] [Related]
8. Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion.
Bengsch B; Johnson AL; Kurachi M; Odorizzi PM; Pauken KE; Attanasio J; Stelekati E; McLane LM; Paley MA; Delgoffe GM; Wherry EJ
Immunity; 2016 Aug; 45(2):358-73. PubMed ID: 27496729
[TBL] [Abstract][Full Text] [Related]
9. T Cell factor 1 represses CD8+ effector T cell formation and function.
Tiemessen MM; Baert MR; Kok L; van Eggermond MC; van den Elsen PJ; Arens R; Staal FJ
J Immunol; 2014 Dec; 193(11):5480-7. PubMed ID: 25355919
[TBL] [Abstract][Full Text] [Related]
10. Type-I IFN drives the differentiation of short-lived effector CD8+ T cells in vivo.
Wiesel M; Crouse J; Bedenikovic G; Sutherland A; Joller N; Oxenius A
Eur J Immunol; 2012 Feb; 42(2):320-9. PubMed ID: 22102057
[TBL] [Abstract][Full Text] [Related]
11. UTX promotes CD8
Mitchell JE; Lund MM; Starmer J; Ge K; Magnuson T; Shpargel KB; Whitmire JK
Cell Rep; 2021 Apr; 35(2):108966. PubMed ID: 33852868
[TBL] [Abstract][Full Text] [Related]
12. Antigen-driven effector CD8 T cell function regulated by T-bet.
Sullivan BM; Juedes A; Szabo SJ; von Herrath M; Glimcher LH
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15818-23. PubMed ID: 14673093
[TBL] [Abstract][Full Text] [Related]
13. Restoring function in exhausted CD8 T cells during chronic viral infection.
Barber DL; Wherry EJ; Masopust D; Zhu B; Allison JP; Sharpe AH; Freeman GJ; Ahmed R
Nature; 2006 Feb; 439(7077):682-7. PubMed ID: 16382236
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection.
Kao C; Oestreich KJ; Paley MA; Crawford A; Angelosanto JM; Ali MA; Intlekofer AM; Boss JM; Reiner SL; Weinmann AS; Wherry EJ
Nat Immunol; 2011 May; 12(7):663-71. PubMed ID: 21623380
[TBL] [Abstract][Full Text] [Related]
15. CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus.
Thomsen AR; Nansen A; Christensen JP; Andreasen SO; Marker O
J Immunol; 1998 Nov; 161(9):4583-90. PubMed ID: 9794385
[TBL] [Abstract][Full Text] [Related]
16. ADAP and SKAP55 deficiency suppresses PD-1 expression in CD8+ cytotoxic T lymphocytes for enhanced anti-tumor immunotherapy.
Li C; Li W; Xiao J; Jiao S; Teng F; Xue S; Zhang C; Sheng C; Leng Q; Rudd CE; Wei B; Wang H
EMBO Mol Med; 2015 Jun; 7(6):754-69. PubMed ID: 25851535
[TBL] [Abstract][Full Text] [Related]
17. PD-1+ stemlike CD8 T cells are resident in lymphoid tissues during persistent LCMV infection.
Im SJ; Konieczny BT; Hudson WH; Masopust D; Ahmed R
Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4292-4299. PubMed ID: 32034098
[TBL] [Abstract][Full Text] [Related]
18. Glycogen Synthase Kinase 3 Inactivation Compensates for the Lack of CD28 in the Priming of CD8
Taylor A; Rudd CE
Front Immunol; 2017; 8():1653. PubMed ID: 29312284
[TBL] [Abstract][Full Text] [Related]
19. A functional subset of CD8
Myers LM; Tal MC; Torrez Dulgeroff LB; Carmody AB; Messer RJ; Gulati G; Yiu YY; Staron MM; Angel CL; Sinha R; Markovic M; Pham EA; Fram B; Ahmed A; Newman AM; Glenn JS; Davis MM; Kaech SM; Weissman IL; Hasenkrug KJ
Nat Commun; 2019 Feb; 10(1):794. PubMed ID: 30770827
[TBL] [Abstract][Full Text] [Related]
20. Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor.
Zajac AJ; Vance RE; Held W; Sourdive DJ; Altman JD; Raulet DH; Ahmed R
J Immunol; 1999 Nov; 163(10):5526-34. PubMed ID: 10553080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
